PSORIASIS-TARGETS TH - Psoriasis-Targets and Therapy

Publications

  1. 2024
  2. Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries

    Valencia López, M. J., Stephan, B., Meineke, A., Wolf, S., Thaci, D., Mrowietz, U., Andrees, V., Rustenbach, S. J., Reich, K., Thalmann, L., Bogena, H., Staubach, P., von Kiedrowski, R. M. & Augustin, M., 2024, In: PSORIASIS-TARGETS TH. 14, p. 29-38 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2021
  4. Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison

    Hampton, P., Borg, E., Hansen, J. B. & Augustin, M., 2021, In: PSORIASIS-TARGETS TH. 11, p. 123-131 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review